This topic contains a solution. Click here to go to the answer

Author Question: In a high-risk study, the researcher must provide the participants with a. a debriefing. b. an ... (Read 36 times)

imanialler

  • Hero Member
  • *****
  • Posts: 539
In a high-risk study, the researcher must provide the participants with
 
  a. a debriefing.
  b. an appropriate phone number in case of problems that persist after participation in the research.
  c. a guarantee of confidentiality.
  d. all of these

Question 2

Wilcoxon rank-sum test is to _____ as Wilcoxon matched-pairs signed-ranks T test is to _____.
 
  a. ordinal data; nominal data
 b. interval data, ordinal data
 c. between-subject design; within-subjects design
  d. within-subjects design; between-subjects design



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

EAN94

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

D

Answer to Question 2

c




imanialler

  • Member
  • Posts: 539
Reply 2 on: Jun 19, 2018
:D TYSM


Jossy

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

For a complete list of videos, visit our video library